Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association

Claudio Marcocci; Torquil Watt; Maria Antonietta Altea; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Jacques Orgiazzi; Luigi Bartalena; European Group of Graves' Orbitopathy

doi:10.1530/EJE-11-0779

Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association

Claudio Marcocci
, Torquil Watt
, Maria Antonietta Altea
, Åse Krogh Rasmussen
, Ulla Feldt-Rasmussen
, Jacques Orgiazzi
, Luigi Bartalena
, European Group of Graves' Orbitopathy

109 Citationer (Scopus)

Abstract

The objective of this study was to investigate the side effects of glucocorticoid (GC) therapy observed by European thyroidologists during the treatment of Graves' orbitopathy (GO).

Originalsprog	Engelsk
Tidsskrift	European Journal of Endocrinology
Vol/bind	166
Udgave nummer	2
Sider (fra-til)	247-53
Antal sider	7
ISSN	0804-4643
DOI	https://doi.org/10.1530/EJE-11-0779
Status	Udgivet - 2012

Adgang til dokumentet

10.1530/EJE-11-0779

Citationsformater

Marcocci, C., Watt, T., Altea, M. A., Rasmussen, Å. K., Feldt-Rasmussen, U., Orgiazzi, J., Bartalena, L., & European Group of Graves' Orbitopathy (2012). Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. European Journal of Endocrinology, 166(2), 247-53. https://doi.org/10.1530/EJE-11-0779

Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. / Marcocci, Claudio; Watt, Torquil; Altea, Maria Antonietta et al.
I: European Journal of Endocrinology, Bind 166, Nr. 2, 2012, s. 247-53.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Marcocci, C, Watt, T, Altea, MA, Rasmussen, ÅK , Feldt-Rasmussen, U, Orgiazzi, J, Bartalena, L & European Group of Graves' Orbitopathy 2012, 'Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association', European Journal of Endocrinology, bind 166, nr. 2, s. 247-53. https://doi.org/10.1530/EJE-11-0779

@article{d123e49aaf53434a84a8e383bc705105,

title = "Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association",

abstract = "The objective of this study was to investigate the side effects of glucocorticoid (GC) therapy observed by European thyroidologists during the treatment of Graves' orbitopathy (GO).",

keywords = "Adult, Adverse Drug Reaction Reporting Systems, Aged, Committee Membership, Data Collection, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Drug Toxicity, Endocrinology, Europe, Female, Glucocorticoids, Graves Ophthalmopathy, Humans, Male, Methylprednisolone, Middle Aged, Physician's Practice Patterns, Questionnaires, Societies, Medical, Thyroid Gland, Young Adult",

author = "Claudio Marcocci and Torquil Watt and Altea, \{Maria Antonietta\} and Rasmussen, \{{\AA}se Krogh\} and Ulla Feldt-Rasmussen and Jacques Orgiazzi and Luigi Bartalena and \{European Group of Graves' Orbitopathy\}",

year = "2012",

doi = "10.1530/EJE-11-0779",

language = "English",

volume = "166",

pages = "247--53",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy

T2 - a questionnaire survey among members of the European Thyroid Association

AU - Marcocci, Claudio

AU - Watt, Torquil

AU - Altea, Maria Antonietta

AU - Rasmussen, Åse Krogh

AU - Feldt-Rasmussen, Ulla

AU - Orgiazzi, Jacques

AU - Bartalena, Luigi

AU - European Group of Graves' Orbitopathy

PY - 2012

Y1 - 2012

N2 - The objective of this study was to investigate the side effects of glucocorticoid (GC) therapy observed by European thyroidologists during the treatment of Graves' orbitopathy (GO).

AB - The objective of this study was to investigate the side effects of glucocorticoid (GC) therapy observed by European thyroidologists during the treatment of Graves' orbitopathy (GO).

KW - Adult

KW - Adverse Drug Reaction Reporting Systems

KW - Aged

KW - Committee Membership

KW - Data Collection

KW - Dose-Response Relationship, Drug

KW - Drug Administration Routes

KW - Drug Administration Schedule

KW - Drug Toxicity

KW - Endocrinology

KW - Europe

KW - Female

KW - Glucocorticoids

KW - Graves Ophthalmopathy

KW - Humans

KW - Male

KW - Methylprednisolone

KW - Middle Aged

KW - Physician's Practice Patterns

KW - Questionnaires

KW - Societies, Medical

KW - Thyroid Gland

KW - Young Adult

U2 - 10.1530/EJE-11-0779

DO - 10.1530/EJE-11-0779

M3 - Journal article

C2 - 22058081

SN - 0804-4643

VL - 166

SP - 247

EP - 253

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 2

ER -

Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater